Pulmonary Diseases in Patients with Classical Hodgkin Lymphoma
According to a study based on Danish data, patients with classical Hodgkin lymphoma have a notably higher risk of pulmonary diseases, especially interstitial lung diseases, following intensive chemotherapy treatment. This highlights the need for early detection and careful monitoring of pulmonary symptoms in long-term survivors.